Italia markets open in 4 hours 7 minutes
Dow Jones
40.003,59 +134,19 (+0,34%) Nasdaq
16.685,97 -12,33 (-0,07%) Nikkei 225
39.346,92 +559,54 (+1,44%) EUR/USD
1,0878 +0,0006 (+0,05%) Bitcoin EUR
61.379,03 -407,57 (-0,66%) CMC Crypto 200
1.361,03 -12,81 (-0,93%)
JNJ Jun 2024 150.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 03:58PM EDT. Mercato aperto.
| Chiusura precedente | 4,62 |
| Aperto | 5,15 |
| Denaro | 4,95 |
| Lettera | 5,25 |
| Prezzo d'esercizio | 150,00 |
| Scadenza | 2024-06-21 |
| Min-Max giorno | 4,46 - 5,15 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 5,11k |
GlobeNewswireAlvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA
© 2024 Yahoo. Tutti i diritti riservati.